Numinus Wellness Announces Corporate Update
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) announced key leadership changes, with Michael Tan appointed as CEO, succeeding Payton Nyquvest who transitions to Executive Chair. Tan, who joined as COO in 2019 and became President in 2022, has overseen operations, M&A activities, and organizational realignments. In his new role, he will focus on strengthening clinical research and practitioner training programs while addressing emerging mental health care opportunities.
Nyquvest will remain actively involved in corporate strategy, investor relations, and strategic partnerships. The company also announced the resignation of Allen Morishita from its Board of Directors, who has served since Numinus' inception.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) ha annunciato importanti cambiamenti nel suo leadership, con Michael Tan nominato CEO, in seguito a Payton Nyquvest che passerà al ruolo di Presidente Esecutivo. Tan, che è entrato come COO nel 2019 e è diventato Presidente nel 2022, ha supervisionato le operazioni, le attività di M&A e i riallineamenti organizzativi. Nel suo nuovo ruolo, si concentrerà sul rafforzamento della ricerca clinica e dei programmi di formazione per i professionisti, affrontando al contempo le opportunità emergenti nella cura della salute mentale.
Nyquvest rimarrà attivamente coinvolto nella strategia aziendale, nelle relazioni con gli investitori e nelle partnership strategiche. L'azienda ha anche annunciato le dimissioni di Allen Morishita dal suo Consiglio di Amministrazione, ruolo che ha occupato sin dalla fondazione di Numinus.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) anunció cambios clave en su liderazgo, con Michael Tan nombrado CEO, sucediendo a Payton Nyquvest, quien pasará a ser Presidente Ejecutivo. Tan, que se unió como COO en 2019 y se convirtió en Presidente en 2022, ha supervisado las operaciones, las actividades de fusiones y adquisiciones, y los realineamientos organizativos. En su nuevo rol, se centrará en fortalecer la investigación clínica y los programas de capacitación para profesionales, mientras aborda las oportunidades emergentes en el cuidado de la salud mental.
Nyquvest seguirá involucrado activamente en la estrategia corporativa, las relaciones con los inversores y las asociaciones estratégicas. La compañía también anunció la renuncia de Allen Morishita de su Junta Directiva, quien ha estado sirviendo desde la creación de Numinus.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF)는 주요 리더십 변화 소식을 발표했으며, Michael Tan이 CEO로 임명되었습니다. 그는 Payton Nyquvest를 이어 Executive Chair로 전환합니다. Tan은 2019년에 COO로 합류하였고, 2022년에 사장이 되었으며, 운영, M&A 활동, 조직 재편을 감독하였습니다. 그의 새로운 역할에서 그는 임상 연구 및 전문가 교육 프로그램 강화에 집중하며, 떠오르는 정신 건강 치료 기회를 다룰 것입니다.
Nyquvest는 여전히 기업 전략, 투자자 관계 및 전략적 파트너십에 적극적으로 참여할 것입니다. 회사는 또한 Numinus가 설립된 이후부터 이사회에서 활동해 온 Allen Morishita의 사임을 발표했습니다.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) a annoncé des changements clés dans son leadership, avec Michael Tan nommé CEO, succédant à Payton Nyquvest qui devient Président Exécutif. Tan, qui a rejoint en tant que COO en 2019 et est devenu Président en 2022, a supervisé les opérations, les activités de fusions et acquisitions, et les réalignements organisationnels. Dans son nouveau rôle, il se concentrera sur le renforcement de la recherche clinique et des programmes de formation pour les praticiens, tout en abordant les opportunités émergentes dans le domaine des soins de santé mentale.
Nyquvest restera activement impliqué dans la stratégie d'entreprise, les relations avec les investisseurs et les partenariats stratégiques. L'entreprise a également annoncé la démission d'Allen Morishita de son Conseil d'Administration, qui a servi depuis la création de Numinus.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) gab bedeutende Änderungen in der Führung bekannt, wobei Michael Tan als CEO ernannt wurde, um Payton Nyquvest nachzufolgen, der zum Executive Chair wechselt. Tan, der 2019 als COO eintrat und 2022 Präsident wurde, hat die Betriebsabläufe, M&A-Aktivitäten und organisatorische Neuausrichtungen überwacht. In seiner neuen Rolle wird er sich darauf konzentrieren, die klinische Forschung und die Ausbildungsprogramme für Fachkräfte zu stärken, während er sich mit aufkommenden Möglichkeiten im Bereich der psychischen Gesundheitsversorgung befasst.
Nyquvest wird weiterhin aktiv in die Unternehmensstrategie, die Investorenbeziehungen und strategische Partnerschaften eingebunden sein. Das Unternehmen gab auch die Rücktritt von Allen Morishita aus dem Board of Directors bekannt, der seit der Gründung von Numinus tätig war.
- Seamless leadership transition with experienced internal candidate
- Former CEO remains involved as Executive Chair maintaining strategic continuity
- New CEO brings extensive operational experience from major corporations
- None.
Michael Tan appointed Chief Executive Officer, with Payton Nyquvest appointed Executive Chair.
Michael Tan has been appointed CEO of the Company, succeeding Payton Nyquvest, who will transition to the role of Executive Chair. Michael joined Numinus as Chief Operating Officer in 2019, prior to its initial listing, and added the role of President to his responsibilities in 2022. Over the years, he has overseen the Company's operations, M&A activities, and organizational realignments. In his new role, Michael will prioritize strengthening Numinus' clinical research and practitioner training programs while aligning the Company's focus to better address emerging opportunities in mental health care. Before joining Numinus, Michael held senior leadership positions at organizations including the BC Liquor Distribution Branch, Hudson's Bay, Saks Fifth Avenue, and UPS.
"I am committed to leading Numinus forward and pursuing opportunities for growth where we can create meaningful impact," said Michael Tan, CEO of Numinus. "Our efforts will remain focused on advancing the areas of the business that show the most promise."
In his new role as Executive Chair, Payton Nyquvest will continue to play an active role in the Company, focusing on informing on corporate strategy, investor relations, and strategic partnerships. As a pioneer in the psychedelic therapy sector, Numinus will benefit from his extensive experience, network, and corporate finance acumen.
"As I transition from CEO to Executive Chair, I look forward to supporting the leadership team and contributing to the Company's ongoing priorities," added Payton Nyquvest.
The Company also announced that Allen Morishita has resigned from its Board of Directors. Allen has served on the Board since Numinus' inception, and the Company thanks him for his expert guidance and counsel.
About Numinus
Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – technology-driven clinic support, clinical trial research and comprehensive practitioner training – is at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, and Instagram.
Forward-looking statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements, and other risks that are set forth in our annual information form dated November 29, 2023, and available on SEDAR at www.sedarplus.ca. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. Numinus does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/numinus-wellness-announces-corporate-update-302359132.html
SOURCE Numinus Wellness Inc.
FAQ
Who is the new CEO of Numinus Wellness (NUMIF) as of January 2024?
What is Michael Tan's background at Numinus Wellness (NUMIF)?
What will be Michael Tan's priorities as new CEO of Numinus (NUMIF)?
What role will former CEO Payton Nyquvest have at Numinus (NUMIF)?
